Gain Therapeutics, Inc. (GANX)
1.26
-0.03
(-2.33%)
USD |
NASDAQ |
Oct 23, 16:00
1.33
+0.07
(+5.56%)
After-Hours: 20:00
Gain Therapeutics EPS Diluted (Quarterly) : -0.109 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.109 |
| March 31, 2026 | -0.1328 |
| December 31, 2025 | -0.1132 |
| September 30, 2025 | -0.151 |
| June 30, 2025 | -0.1915 |
| March 31, 2025 | -0.1579 |
| December 31, 2024 | -0.1389 |
| September 30, 2024 | -0.1691 |
| June 30, 2024 | -0.4238 |
| March 31, 2024 | -0.2233 |
| December 31, 2023 | -0.2915 |
| September 30, 2023 | -0.3715 |
| June 30, 2023 | -0.6206 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4304 |
| December 31, 2022 | -0.3934 |
| September 30, 2022 | -0.3836 |
| June 30, 2022 | -0.4279 |
| March 31, 2022 | -0.2754 |
| December 31, 2021 | -0.271 |
| September 30, 2021 | -0.3926 |
| June 30, 2021 | -0.2995 |
| March 31, 2021 | -0.5033 |
| December 31, 2020 | -0.1394 |
| September 30, 2020 | -0.0669 |
| December 31, 2019 | -0.0598 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.676M |
| Total Expenses (Quarterly) | 4.676M |
| Enterprise Value | 42.13M |
| Earnings Yield | -40.16% |
| Normalized Earnings Yield | -40.16 |